A registry study of relapsed or refractory multiple myeloma pre‐exposed to three or more prior therapies including a proteasome inhibitor, an immunomodulatory agent and CD38‐target...

por Elsada, Ahmed, Zalin‐Miller, Amy, Knott, Craig, Caravotas, Leonidas
Publicado 2021

Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017

por Zalin-Miller, Amy, Jose, Sophie, Knott, Craig, Paley, Lizz, Tataru, Daniela, Morement, Helen, Toledano, Mireille B, Khan, Shahid A
Publicado 2023